ArticleSmall methods2026
Single-Particle Characterization Reveals Heterogeneous Extracellular Vesicle Fusion with Liposomes.
Article in Small methods, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- Extracellular Vesicle-Lipid Hybrid Systems for RNA Delivery in Cancer: Structural Classification, Functional Delivery, and Translational Challenges.Pharmaceutics · 2026Review
- Liposomal drug delivery for lung cancer therapy: progress, challenges, and future perspectives.Molecular cancer · 2026Review
- From LNPs to hybrid nanocarriers: development, challenges and redesign of non-viral gene delivery.Journal of nanobiotechnology · 2026Review
- The 'sugar' side of extracellular vesicle-glycome: a panorama from basic characteristics, deciphering technologies, functions, to applications.Journal of nanobiotechnology · 2026Review
- Macrophage-derived extracellular vesicles in the remodeling of the prostate cancer immune microenvironment and therapeutic resistance.Journal of translational medicine · 2026Review
- Mesenchymal stem cells-derived extracellular vesicles as a novel drug delivery carrier: engineering strategies and clinical safety estimation.Frontiers in molecular biosciences · 2026Review
- From Uptake to Therapeutic Function in Engineered Exosome Delivery Systems.Research (Washington, D.C.) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Fusion of extracellular vesicles (EVs) with liposomes can be used to alter the properties of EVs to enhance their drug delivery capabilities. However, metrics for assessing fusion are not well established. Fusion efficiency, the most frequently provided metric, is often characterized in bulk, clouding distribution of fusion across heterogeneous EV populations, and lacking assessment of more precise physical effects of fusion. Here we applied orthogonal single-particle techniques including nanoparticle-tracking analysis (NTA), resistive-pulse sensing (RPS), nanoscale flow cytometry, interferometric fluorescence imaging, and laser trapping Raman spectroscopy (LTRS), each with different limitations, to examine the effects of fusion. All techniques reduced particle number, while single-particle fluorescence analyses revealed substantial differences in fused-particle yield. Nanoscale flow cytometry and interferometric fluorescence imaging consistently identified freeze-thaw and sonication as producing the highest numbers of fused vesicles, with freeze-thaw generating the lowest proportion of non-fused EVs and liposomes. Interferometric fluorescence imaging further showed that fused vesicles retained native EV membrane proteins, but that fusion also reduced the abundance of these proteins, indicating membrane perturbation. We introduce here a multi-metric framework to evaluate fusion efficiency, purity, and physical alterations to vesicles, as a basis for comparing techniques and to support future optimization of engineered EV formulations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.